151 related articles for article (PubMed ID: 24439396)
1. Cell-selective intracellular drug delivery using doxorubicin and α-helical peptides conjugated to gold nanoparticles.
Park H; Tsutsumi H; Mihara H
Biomaterials; 2014 Mar; 35(10):3480-7. PubMed ID: 24439396
[TBL] [Abstract][Full Text] [Related]
2. Cell penetration and cell-selective drug delivery using α-helix peptides conjugated with gold nanoparticles.
Park H; Tsutsumi H; Mihara H
Biomaterials; 2013 Jul; 34(20):4872-9. PubMed ID: 23545289
[TBL] [Abstract][Full Text] [Related]
3. Gold nanoparticles with a monolayer of doxorubicin-conjugated amphiphilic block copolymer for tumor-targeted drug delivery.
Prabaharan M; Grailer JJ; Pilla S; Steeber DA; Gong S
Biomaterials; 2009 Oct; 30(30):6065-75. PubMed ID: 19674777
[TBL] [Abstract][Full Text] [Related]
4. Enhanced and selective permeability of gold nanoparticles functionalized with cell penetrating peptide derived from maurocalcine animal toxin.
Khamehchian S; Nikkhah M; Madani R; Hosseinkhani S
J Biomed Mater Res A; 2016 Nov; 104(11):2693-700. PubMed ID: 27324825
[TBL] [Abstract][Full Text] [Related]
5. Using doxorubicin and siRNA-loaded heptapeptide-conjugated nanoparticles to enhance chemosensitization in epidermal growth factor receptor high-expressed breast cancer cells.
Liu CW; Lin WJ
J Drug Target; 2013 Sep; 21(8):776-86. PubMed ID: 23829387
[TBL] [Abstract][Full Text] [Related]
6. Peptide-mediated cell penetration and targeted delivery of gold nanoparticles into lysosomes.
Dekiwadia CD; Lawrie AC; Fecondo JV
J Pept Sci; 2012 Aug; 18(8):527-34. PubMed ID: 22764089
[TBL] [Abstract][Full Text] [Related]
7. Cell-Penetrating Peptide-Modified Gold Nanoparticles for the Delivery of Doxorubicin to Brain Metastatic Breast Cancer.
Morshed RA; Muroski ME; Dai Q; Wegscheid ML; Auffinger B; Yu D; Han Y; Zhang L; Wu M; Cheng Y; Lesniak MS
Mol Pharm; 2016 Jun; 13(6):1843-54. PubMed ID: 27169484
[TBL] [Abstract][Full Text] [Related]
8. A pH-responsive α-helical cell penetrating peptide-mediated liposomal delivery system.
Zhang Q; Tang J; Fu L; Ran R; Liu Y; Yuan M; He Q
Biomaterials; 2013 Oct; 34(32):7980-93. PubMed ID: 23891517
[TBL] [Abstract][Full Text] [Related]
9. Cellular uptake and fate of PEGylated gold nanoparticles is dependent on both cell-penetration peptides and particle size.
Oh E; Delehanty JB; Sapsford KE; Susumu K; Goswami R; Blanco-Canosa JB; Dawson PE; Granek J; Shoff M; Zhang Q; Goering PL; Huston A; Medintz IL
ACS Nano; 2011 Aug; 5(8):6434-48. PubMed ID: 21774456
[TBL] [Abstract][Full Text] [Related]
10. Modification of calcium carbonate based gene and drug delivery systems by a cell-penetrating peptide.
Zhao D; Zhuo RX; Cheng SX
Mol Biosyst; 2012 Oct; 8(12):3288-94. PubMed ID: 23086311
[TBL] [Abstract][Full Text] [Related]
11. Cancer stem cell therapy using doxorubicin conjugated to gold nanoparticles via hydrazone bonds.
Sun TM; Wang YC; Wang F; Du JZ; Mao CQ; Sun CY; Tang RZ; Liu Y; Zhu J; Zhu YH; Yang XZ; Wang J
Biomaterials; 2014 Jan; 35(2):836-45. PubMed ID: 24144908
[TBL] [Abstract][Full Text] [Related]
12. The Primary Mechanism of Cellular Internalization for a Short Cell- Penetrating Peptide as a Nano-Scale Delivery System.
Liu BR; Huang YW; Korivi M; Lo S-Y; Aronstam RS; Lee H-J
Curr Pharm Biotechnol; 2017; 18(7):569-584. PubMed ID: 28828981
[TBL] [Abstract][Full Text] [Related]
13. Doxorubicin conjugated NaYF(4):Yb(3+)/Tm(3+) nanoparticles for therapy and sensing of drug delivery by luminescence resonance energy transfer.
Dai Y; Yang D; Ma P; Kang X; Zhang X; Li C; Hou Z; Cheng Z; Lin J
Biomaterials; 2012 Nov; 33(33):8704-13. PubMed ID: 22938822
[TBL] [Abstract][Full Text] [Related]
14. Doxorubicin-tethered responsive gold nanoparticles facilitate intracellular drug delivery for overcoming multidrug resistance in cancer cells.
Wang F; Wang YC; Dou S; Xiong MH; Sun TM; Wang J
ACS Nano; 2011 May; 5(5):3679-92. PubMed ID: 21462992
[TBL] [Abstract][Full Text] [Related]
15. Efficient induction of apoptosis by doxorubicin coupled to cell-penetrating peptides compared to unconjugated doxorubicin in the human breast cancer cell line MDA-MB 231.
Aroui S; Brahim S; De Waard M; Bréard J; Kenani A
Cancer Lett; 2009 Nov; 285(1):28-38. PubMed ID: 19523755
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of superparamagnetic CaCO3 mesocrystals for multistage delivery in cancer therapy.
Zhao Y; Lu Y; Hu Y; Li JP; Dong L; Lin LN; Yu SH
Small; 2010 Nov; 6(21):2436-42. PubMed ID: 20878636
[TBL] [Abstract][Full Text] [Related]
17. Creation of a novel cell penetrating peptide, using a random 18mer peptides library.
Nomura T; Kawamura M; Shibata H; Abe Y; Ohkawa A; Mukai Y; Sugita T; Imai S; Nagano K; Okamoto T; Tsutsumi Y; Kamada H; Nakagawa S; Tsunoda S
Pharmazie; 2007 Aug; 62(8):569-73. PubMed ID: 17867548
[TBL] [Abstract][Full Text] [Related]
18. Oral biodrug delivery using cell-penetrating peptide.
Khafagy el-S; Morishita M
Adv Drug Deliv Rev; 2012 May; 64(6):531-9. PubMed ID: 22245080
[TBL] [Abstract][Full Text] [Related]
19. Cyclic peptide-capped gold nanoparticles as drug delivery systems.
Nasrolahi Shirazi A; Mandal D; Tiwari RK; Guo L; Lu W; Parang K
Mol Pharm; 2013 Feb; 10(2):500-11. PubMed ID: 22998473
[TBL] [Abstract][Full Text] [Related]
20. Insights into cell penetrating peptide conjugated gold nanoparticles for internalization into bacterial cells.
Kumar M; Tegge W; Wangoo N; Jain R; Sharma RK
Biophys Chem; 2018 Jun; 237():38-46. PubMed ID: 29656216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
